Emergent BioSolutions Inc. (EBS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.3000 |
| Open | 3.4500 |
| Bid | 3.9000 x 800 |
| Ask | 3.9400 x 1300 |
| Day's range | 3.3600 - 4.0200 |
| 52-week range | 1.4200 - 10.8800 |
| Volume | |
| Avg. volume | 5,483,251 |
| Market cap | 203.8M |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -14.8500 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.00 |
- Thomson Reuters StreetEvents
Q1 2024 Emergent BioSolutions Inc Earnings Call
Q1 2024 Emergent BioSolutions Inc Earnings Call
Insider MonkeyEmergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. I’m […]
- GuruFocus.com
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
Emergent BioSolutions Inc (EBS) showcases robust revenue growth and operational efficiency in the first quarter of 2024.
© 2024 Yahoo. All rights reserved.